Top Key Companies for Genome (DNA) Sequencing Market: Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., QIAGEN, Thermo Fisher Scientific Inc..
Global Genome (DNA) Sequencing Market Size was estimated at USD 160.6 million in 2022 and is projected to reach USD 385.85 million by 2028, exhibiting a CAGR of 15.73% during the forecast period.
Global Genome (DNA) Sequencing Market Overview And Scope:
The Global Genome (DNA) Sequencing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Genome (DNA) Sequencing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Genome (DNA) Sequencing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genome (DNA) Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Genome (DNA) Sequencing market.
Global Genome (DNA) Sequencing Market Segmentation
By Type, Genome (DNA) Sequencing market has been segmented into:
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
By Application, Genome (DNA) Sequencing market has been segmented into:
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
Regional Analysis of Genome (DNA) Sequencing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Genome (DNA) Sequencing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Genome (DNA) Sequencing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Genome (DNA) Sequencing market.
Top Key Companies Covered in Genome (DNA) Sequencing market are:
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Genome (DNA) Sequencing Market by Type
5.1 Genome (DNA) Sequencing Market Overview Snapshot and Growth Engine
5.2 Genome (DNA) Sequencing Market Overview
5.3 Next-Generation Sequencing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Next-Generation Sequencing: Geographic Segmentation
5.4 Third Generation DNA Sequencing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Third Generation DNA Sequencing: Geographic Segmentation
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation
Chapter 6: Genome (DNA) Sequencing Market by Application
6.1 Genome (DNA) Sequencing Market Overview Snapshot and Growth Engine
6.2 Genome (DNA) Sequencing Market Overview
6.3 Research Institutes
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Research Institutes: Geographic Segmentation
6.4 Pharmaceutical & Biotechnological Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical & Biotechnological Companies: Geographic Segmentation
6.5 Healthcare Facilities & Diagnostic Centres
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Healthcare Facilities & Diagnostic Centres: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Genome (DNA) Sequencing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Genome (DNA) Sequencing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Genome (DNA) Sequencing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 AGILENT TECHNOLOGIES INC.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BGI
7.4 BIO-RAD LABORATORIES
7.5 DANAHER
7.6 F. HOFFMANN-LA ROCHE LTD.
7.7 GENOME ELECTRIC COMPANY
7.8 ILLUMINA INC.
7.9 INTEGRAGEN
7.10 OXFORD NANOPORE TECHNOLOGIES
7.11 PACIFIC BIOSCIENCES OF CALIFORNIA INC.
7.12 QIAGEN
7.13 THERMO FISHER SCIENTIFIC INC.
Chapter 8: Global Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Next-Generation Sequencing
8.2.2 Third Generation DNA Sequencing
8.2.3 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Research Institutes
8.3.2 Pharmaceutical & Biotechnological Companies
8.3.3 Healthcare Facilities & Diagnostic Centres
Chapter 9: North America Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Next-Generation Sequencing
9.4.2 Third Generation DNA Sequencing
9.4.3 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Research Institutes
9.5.2 Pharmaceutical & Biotechnological Companies
9.5.3 Healthcare Facilities & Diagnostic Centres
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Next-Generation Sequencing
10.4.2 Third Generation DNA Sequencing
10.4.3 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Research Institutes
10.5.2 Pharmaceutical & Biotechnological Companies
10.5.3 Healthcare Facilities & Diagnostic Centres
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Next-Generation Sequencing
11.4.2 Third Generation DNA Sequencing
11.4.3 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Research Institutes
11.5.2 Pharmaceutical & Biotechnological Companies
11.5.3 Healthcare Facilities & Diagnostic Centres
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Next-Generation Sequencing
12.4.2 Third Generation DNA Sequencing
12.4.3 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Research Institutes
12.5.2 Pharmaceutical & Biotechnological Companies
12.5.3 Healthcare Facilities & Diagnostic Centres
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Next-Generation Sequencing
13.4.2 Third Generation DNA Sequencing
13.4.3 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Research Institutes
13.5.2 Pharmaceutical & Biotechnological Companies
13.5.3 Healthcare Facilities & Diagnostic Centres
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Genome (DNA) Sequencing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Next-Generation Sequencing
14.4.2 Third Generation DNA Sequencing
14.4.3 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Research Institutes
14.5.2 Pharmaceutical & Biotechnological Companies
14.5.3 Healthcare Facilities & Diagnostic Centres
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Genome (DNA) Sequencing Scope:
|
Report Data
|
Genome (DNA) Sequencing Market
|
|
Genome (DNA) Sequencing Market Size in 2025
|
USD XX million
|
|
Genome (DNA) Sequencing CAGR 2025 - 2032
|
XX%
|
|
Genome (DNA) Sequencing Base Year
|
2024
|
|
Genome (DNA) Sequencing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., QIAGEN, Thermo Fisher Scientific Inc..
|
|
Key Segments
|
By Type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
By Applications
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
|
